Physician profile

David Joseph Dowling

Pain Medicine (Physical Medicine & Rehabilitation) · Memphis, TN

NPI 1548263692

$162.68

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$70.39

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bioventus LLC $30.26 2024 Exogen Ultrasound Bone Healing System
Orthofix Medical, INC. $23.94 2019
Avanos Medical $22.18 2019
Mimedx Group, INC. $21.64 2024
Pacira Therapeutics, INC. $19.74 2019
Medtronic, INC. $18.49 2024 Intellis Adaptivestim
Depuy Synthes Sales INC. $14.71 2019
Endo Pharmaceuticals INC. $11.72 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Joseph Dowling

$162.68

in general payments reported 2019-2025

Years
2019-2024
Top company
Bioventus LLC

https://glasscript.com/doctor/805863/david-joseph-dowling

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.